Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Rheumatol Adv Pract ; 8(2): rkae033, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38560643

RESUMO

Objectives: The need for glucocorticoid-sparing drugs (GCSD) remains an important issue and is an unmet need in the treatment of polymyalgia rheumatica (PMR). We therefore aimed to assess the effectiveness and safety of methotrexate (MTX) and of leflunomide (LEF) in daily clinical practice in PMR patients from Argentina. Methods: A multicentre and observational study (medical records review) of PMR patients seen between 2007 and 2023, who had at least three months of follow-up after starting a GCSD, either MTX or LEF, was performed. Results are expressed as medians and interquartile ranges [25th-75th (IQR)] for continuous variables and percentages for categorical ones. The two treatment groups were compared using χ2 test for categorical variables, Mann-Whitney U test for continuous variables and the log-rank test for time-to-event data. Crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using logistic regression. In all cases, a p-value <0.05 was considered statistically significant. Results: One-hundred and eighty-six patients (79% female) with a median age of 72 years (IQR, 65-77 years) were included. One-hundred and forty-three patients (77%) were prescribed MTX (15, IQR 10-15) and 43 (23%) LEF (20 mg, fixed dose). Flare-ups (relapses and recurrences) occurred in 13 patients (7%) and were comparable between both groups. Persistent GCSD intake was observed in 145 patients (78%). Glucocorticoid (GC) withdrawal was achieved in 67 of these 145 patients (46%) and this occurred more frequently in the LEF group (P = 0.001). Furthermore, time until prednisone discontinuation was shorter in the LEF-treated patients (4.7 months, IQR 3-20 on LEF versus 31.8 months, IQR 10-82 on MTX, P = 0.000). Remission was found more frequently in the LEF group (P = 0.003). In the multivariate analysis, the probability of remission was higher with LEF therapy (P = 0.010) and this finding persisted in the subgroup analysis who were followed up < 40 months (OR 3.12, 95% CI = 1.30-7.47, P = 0.011). Conclusions: This study demonstrated the clinical effectiveness of LEF and even its superiority in achieving remission when compared with MTX as GCSD in PMR patients. Further research is needed to support these findings.

2.
J Rheumatol ; 50(1): 93-97, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36243415

RESUMO

OBJECTIVE: To estimate incidence and prevalence of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in a university hospital-based health management organization (Hospital Italiano Medical Care Program) in Argentina. METHODS: Overall and sex-specific incidence rates (IRs) and prevalence were calculated (age ≥ 50 yrs). Incidence study followed members with continuous affiliation ≥ 1 year from January 2000 to December 2015. Diagnosis as per the 2012 European Alliance of Associations for Rheumatology/American College of Rheumatology (ACR) criteria for PMR or the ACR 1990 criteria for GCA. Prevalence was calculated on January 1, 2015. RESULTS: There were 176,558 persons who contributed a total of 1,046,620 person-years (PY). Of these, 825 developed PMR, with an IR (per 100,000 PY) of 78.8 (95% CI 73.4-84.2) overall, 90.1 (95% CI 82.9-97.2) for women, and 58.9 (95% CI 51.1-66.6) for men. Ninety persons developed GCA; the IR was 8.6 (95% CI 6.8-10.4) overall, 11.1 (95% CI 8.5-10.6) for women, and 4.2 (2.2-6.3) for men. There were 205 prevalent PMR cases and 23 prevalent GCA cases identified from a population of 80,335. Prevalence of PMR was 255 per 100,000 (95% CI 220-290) overall, 280 (95% CI 234-325) for women, and 209 (95% CI 150-262) for men; and the prevalence of GCA was 28.6 per 100,000 (95% CI 16.9-40.3) overall, 36.4 (95% CI 20.1-52.8) for women, and 14.2 (95% CI 0.3-28.1) for men. CONCLUSION: This is the first study of incidence and prevalence of PMR and GCA in Argentina. There were similarities and differences with cohorts from other parts of the world, but population-based epidemiologic studies in Latin America are needed.


Assuntos
Arterite de Células Gigantes , Polimialgia Reumática , Masculino , Humanos , Feminino , Pessoa de Meia-Idade , Arterite de Células Gigantes/epidemiologia , Arterite de Células Gigantes/diagnóstico , Polimialgia Reumática/epidemiologia , Polimialgia Reumática/diagnóstico , Incidência , Prevalência , Argentina/epidemiologia , Atenção à Saúde
3.
Radiol Bras ; 55(6): 346-352, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36514685

RESUMO

Objective: To describe the prevalence of magnetic resonance imaging (MRI) findings in patients with the clinical diagnosis of polymyalgia rheumatica (PMR). Materials and Methods: Sixteen consecutive patients with untreated PMR, meeting the American College of Rheumatology criteria, underwent MRI examinations of the shoulder(s), hip(s), or both, depending on clinical complaints. Six patients also underwent MRI of the spine. Results: We evaluated 24 shoulders, among which we identified subacromial-subdeltoid bursitis in 21 (87.5%), glenohumeral joint effusion in 17 (70.8%), and fluid distention of the long head of the biceps tendon sheath in 15 (62.5%). Peritendinitis and capsular edema were observed in 21 (87.5%) and 17 (70.8%) shoulders, respectively. We also evaluated 17 hips, identifying hip joint effusion in 12 (70.6%), trochanteric bursitis in 11 (64.7%), peritendinitis in 17 (100%), and capsular edema in 14 (82.4%). All six of the patients who underwent MRI of the spine were found to have interspinous bursitis. Conclusion: Subacromial-subdeltoid bursitis, glenohumeral joint effusion, and hip joint effusion are common findings in patients with PMR. In addition, such patients appear to be highly susceptible to peritendinitis and capsular edema. There is a need for case-control studies to validate our data and to determine the real impact that these findings have on the diagnosis of PMR by MRI.


Objetivo: Descrever os achados de ressonância magnética (RM) mais prevalentes em pacientes com diagnóstico clínico de polimialgia reumática (PMR). Materiais e Métodos: Dezesseis pacientes com PMR não tratada, classificados pelos critérios do American College of Rheumatology, foram submetidos a RM do ombro e/ou quadril, segundo suas queixas clínicas. Seis pacientes também foram submetidos a RM da coluna. Resultados: Foram avaliados 24 ombros, identificando-se bursite subacromial-subdeltoide em 21 (87,5%), sinovite glenoumeral em 17 (70,8%) e distensão líquida da bainha do tendão da cabeça longa do bíceps em 15 (62,5%). Peritendinite e edema capsular foram observados em 21 (87,5%) e 17 (70,8%) ombros, respectivamente. Dezessete quadris foram analisados, identificando-se sinovite em 12 (70,6%), bursite trocantérica em 11 (64,7%), peritendinite em 17 (100%) e edema capsular em 14 (82,4%). Os seis pacientes que realizaram RM da coluna apresentavam bursite interespinhosa. Conclusão: Bursite subacromial-subdeltoide, sinovite glenoumeral e do quadril são achados de imagem prevalentes em pacientes com PMR. Além disso, achados como peritendinite e edema capsular tiveram alta prevalência nesses pacientes. Estudos de casocontrole devem ser realizados para validar esses dados e estabelecer o real impacto desses achados no diagnóstico de PMR.

4.
Radiol. bras ; Radiol. bras;55(6): 346-352, Nov.-Dec. 2022. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1422517

RESUMO

Abstract Objective: To describe the prevalence of magnetic resonance imaging (MRI) findings in patients with the clinical diagnosis of polymyalgia rheumatica (PMR). Materials and Methods: Sixteen consecutive patients with untreated PMR, meeting the American College of Rheumatology criteria, underwent MRI examinations of the shoulder(s), hip(s), or both, depending on clinical complaints. Six patients also underwent MRI of the spine. Results: We evaluated 24 shoulders, among which we identified subacromial-subdeltoid bursitis in 21 (87.5%), glenohumeral joint effusion in 17 (70.8%), and fluid distention of the long head of the biceps tendon sheath in 15 (62.5%). Peritendinitis and capsular edema were observed in 21 (87.5%) and 17 (70.8%) shoulders, respectively. We also evaluated 17 hips, identifying hip joint effusion in 12 (70.6%), trochanteric bursitis in 11 (64.7%), peritendinitis in 17 (100%), and capsular edema in 14 (82.4%). All six of the patients who underwent MRI of the spine were found to have interspinous bursitis. Conclusion: Subacromial-subdeltoid bursitis, glenohumeral joint effusion, and hip joint effusion are common findings in patients with PMR. In addition, such patients appear to be highly susceptible to peritendinitis and capsular edema. There is a need for case-control studies to validate our data and to determine the real impact that these findings have on the diagnosis of PMR by MRI.


Resumo Objetivo: Descrever os achados de ressonância magnética (RM) mais prevalentes em pacientes com diagnóstico clínico de polimialgia reumática (PMR). Materiais e Métodos: Dezesseis pacientes com PMR não tratada, classificados pelos critérios do American College of Rheumatology, foram submetidos a RM do ombro e/ou quadril, segundo suas queixas clínicas. Seis pacientes também foram submetidos a RM da coluna. Resultados: Foram avaliados 24 ombros, identificando-se bursite subacromial-subdeltoide em 21 (87,5%), sinovite glenoumeral em 17 (70,8%) e distensão líquida da bainha do tendão da cabeça longa do bíceps em 15 (62,5%). Peritendinite e edema capsular foram observados em 21 (87,5%) e 17 (70,8%) ombros, respectivamente. Dezessete quadris foram analisados, identificando-se sinovite em 12 (70,6%), bursite trocantérica em 11 (64,7%), peritendinite em 17 (100%) e edema capsular em 14 (82,4%). Os seis pacientes que realizaram RM da coluna apresentavam bursite interespinhosa. Conclusão: Bursite subacromial-subdeltoide, sinovite glenoumeral e do quadril são achados de imagem prevalentes em pacientes com PMR. Além disso, achados como peritendinite e edema capsular tiveram alta prevalência nesses pacientes. Estudos de caso- controle devem ser realizados para validar esses dados e estabelecer o real impacto desses achados no diagnóstico de PMR.

6.
J Transl Autoimmun ; 4: 100115, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34485886

RESUMO

OBJECTIVE: Polymyalgia rheumatica (PMR) is the most common inflammatory disease in patients over 50 years. Information about the disease in Latin America (LATAM) is scarce. We aimed to evaluate a group of Colombian patients with PMR and to conduct a systematic review of PMR in LATAM. METHODS: A multicentric retrospective study was performed. Medical records of 256 PMR patients were evaluated. Patients were divided into two groups, those fulfilling the 2012 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for PMR and those who did not (i.e., clinical diagnosis). A systematic literature review and meta regression was performed comparing Colombian vs LATAM patients. RESULTS: From 256 patients, 145 (56.6%) fulfilled the 2012 EULAR/ACR criteria, and 111 (43.3%) were classified by clinical diagnosis. Inflammatory bilateral shoulder pain, pelvic girdle aching, morning stiffness >45 min, elevated erythrocyte sedimentation rate (ESR), and C-reactive protein (CPR), and Methotrexate (MTX) prescription were more common in the 2012 EULAR/ACR group. None of the included patients presented overt polyautoimmunity (PolyA), whereas up to 24% exhibited latent PolyA. In addition, these patients showed high frequency of malignancy (7.59%). In the meta regression analysis, Colombian patients exhibited lower ESR levels, and were less likely to develop giant cell arteritis (GCA) as compared to the rest of LATAM data. CONCLUSION: Patients with PMR in LATAM exhibit similar phenotypes from other cohorts worldwide. Malignancy, GCA and latent PolyA should be considered in the routine clinical follow-up of patients with PMR.

7.
Rheumatol Int ; 39(9): 1631-1635, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31327052

RESUMO

Polymyalgia rheumatica (PMR) affects elderly patients and is characterized by pain and stiffness of the shoulder girdle, pelvic girdle and cervical region, which can be associated with the presence of giant cell arteritis. Data on the epidemiology of this disease in Latin America are scarce. In Colombia, the Ministry of Health introduced SISPRO, a tool to collect nation-wide information from the health system. The information collected from SISPRO is available for scientific analysis. Using SISPRO data for the years 2012-2016, an analysis was made on the prevalence and characteristics of patients diagnosed with PMR. This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to PMR, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case. National records report 19,901 individuals diagnosed with PMR and estimated prevalence of 2 cases per 1000 inhabitants over 50 years old (based on a total population of 47,663,162), being more frequent in women (86% of cases), with a female/male ratio of 6.2:1. This is the first study that describes the demographic characteristics of PMR in Colombia. Our results are consistent with the age-related increase in prevalence and gender ratio. Likewise, there are differences between regions, which may be related to ancestry and environmental factors, which require further studies.


Assuntos
Polimialgia Reumática/epidemiologia , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Colômbia/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polimialgia Reumática/diagnóstico , Prevalência , Sistema de Registros , Distribuição por Sexo , Fatores de Tempo
9.
Rev. chil. radiol ; 24(4): 134-141, dic. 2018. tab, ilus
Artigo em Espanhol | LILACS | ID: biblio-978169

RESUMO

Resumen: La arteritis de células gigantes es una vasculitis sistémica frecuente, especialmente en mayores de 50 años. Ante la sospecha clínica el diagnóstico debe ser confirmado con histología o estudios de imágenes. La biopsia de arteria temporal se considera el gold standard, sin embargo, tiene sus limitaciones, una de ellas es la alta tasa de falsos negativos. El estudio por ecotomografía Doppler permite la visualización de las arterias temporales y en manos experimentadas puede constituir un procedimiento diagnóstico alternativo a la biopsia en el estudio inicial de esta entidad. Esta técnica es de fácil acceso, bajo costo, sin riesgos y no expone al paciente a radiación ionizante. En este trabajo revisamos la utilidad clínica de la ecotomografía Doppler en el estudio de la arteria temporal y sus hallazgos imagenológicos en la aproximación diagnóstica a la arteritis de células gigantes, siendo las características de compromiso el engrosamiento parietal arterial hipoecogénico, habitualmente concéntrico, no compresible.


Abstract: Giant cell arteritis is a frequent systemic vasculitis, especially in patients older than 50 years old. When clinically suspected, the diagnosis should be made on the basis of histology or imaging methods. Temporal artery biopsy is considered the gold standard for the diagnosis but it has some caveats, especially the existence of false negatives. Doppler ultrasound study is a low cost, accessible tool that allows visualization of temporal arteries and, in experienced hands, can replace the biopsy in the initial evaluation of the disease, without the risks of ionizing radiation. In this article we review the clinical utility of the temporal artery Doppler ultrasound and its findings in the diagnostic approach of giant cell arteritis, being characteristic a non-compressible, hypoechoic, most commonly concentric arterial wall thickening.


Assuntos
Humanos , Feminino , Idoso , Arterite de Células Gigantes/diagnóstico por imagem , Sinais e Sintomas , Artérias Temporais/patologia , Artérias Temporais/diagnóstico por imagem , Arterite de Células Gigantes/patologia , Arterite de Células Gigantes/terapia , Ultrassonografia Doppler
11.
Rev. colomb. radiol ; 27(2): 4460-4463, 2016. ilus, tab
Artigo em Espanhol | LILACS | ID: biblio-987435

RESUMO

La polimialgia reumática es una enfermedad que generalmente afecta a los individuos mayores de 50 años. Desde 1963 se ha modificado su denominación y clasificación; en la actualidad, para su diagnóstico se cuentan con criterios clínicos e imagenológicos. Entre los criterios imagenológicos se considera especialmente el ultrasonido; sin embargo, la resonancia magnética permite descartar diagnósticos diferenciales y considerar en forma oportuna el diagnóstico de la polimialgia reumática. Esto se destaca en el presente artículo que describe el caso de una paciente de 56 años con antecedentes de perioniquia secundaria a pedicura y, como complicación, una espondilodiscitis. Posteriormente aparece dolor articular simétrico, matutino, en caderas y hombros; por medio de resonancia magnética se establece el diagnóstico del proceso infeccioso inicial y se descarta el compromiso infeccioso articular, lo cual se asocia a criterios clínicos y se diagnostica y trata la polimialgia reumática.


Polymyalgia rheumatica is a disease that usually affects people over 50 years old. Since 1963, its name and classification have been modified; at present, there are clinical and imaging data criteria for its diagnosis. Among the imaging criteria, ultrasound plays a pivotal role; however, magnetic resonance helps to rule out different diagnoses, as well as to clarify the diagnosis of polymyalgia rheumatica. This paper highlights this fact by presenting the case of a 56-year old female patient with a history of paronychia secondary to pedicure, and spondylodiscitis as a complication. Later, she reports symmetrical joint pain in hips and shoulders in the morning; magnetic resonance is used to establish the initial infective process, while infective joint involvement is discarded; it is associated with clinical criteria in order to establish the diagnosis and treatment of polymyalgia rheumatic.


Assuntos
Humanos , Polimialgia Reumática , Reumatologia , Imageamento por Ressonância Magnética , Ultrassonografia
12.
Rev. colomb. reumatol ; 22(2): 104-109, jun. 2015. graf, tab
Artigo em Espanhol | LILACS | ID: lil-770781

RESUMO

La polimialgia reumática es una enfermedad inflamatoria crónica común en la poblacióngeriátrica. Su cuadro clínico se caracteriza por dolor en la cintura escapular, región cervicaly caderas, asociado frecuentemente a rigidez de estas áreas articulares posterior a periodosde reposo. El diagnóstico de esta patología es clínico y debe hacerse posterior a descartarotras entidades como artritis reumatoide o espondiloartropatía de aparición tardía. Hastael momento, no hay criterios de clasificación estandarizados y aceptados, por lo que recientementese desarrollaron unos criterios provisionales por parte del Colegio Americano deReumatología y de la Liga Europea Contra el Reumatismo. La polimialgia reumática se asociahasta en un 30% de los pacientes con arteritis de células gigantes. El principal tratamientoes con dosis bajas de glucocorticoides, con lo cual los pacientes presentan rápida mejoríasintomática...


Assuntos
Humanos , Corticosteroides , Arterite de Células Gigantes , Dor , Polimialgia Reumática
13.
Scott Med J ; 60(1): 50-7, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25201886

RESUMO

OBJECTIVES: On the 125th anniversary of the first recognised publication on polymyalgia rheumatica, a review of the literature was undertaken to assess what progress has been made from the point of view of the epidemiology of this disease and whether such studies have advanced our knowledge of its aetiopathogenesis and management. METHODS: The authors searched Medline and PubMed using the search terms 'polymyalgia rheumatica', 'giant cell arteritis' and 'temporal arteritis'. As much as possible, efforts were made to focus on studies where polymyalgia and giant cell arteritis were treated as separate entities. The selection of articles was influenced by the authors' bias that polymyalgia rheumatica is a separate clinical condition from giant cell arteritis and that, as yet, the diagnosis is a clinical one. RESULTS: This review has shown that, following the recognition of polymyalgia as a distinct clinical problem of the elderly, the results of a considerable amount of research efforts investigating the populations susceptible, the geographic distribution of these affected populations and the associated sociological and genetic elements that might contribute to its occurrence, polymyalgia rheumatica remains a difficult problem for the public health services of the developed world. CONCLUSIONS: Polymyalgia rheumatica remains a clinical enigma and its relationship to giant cell arteritis is no clearer now than it has been for the past 125 years. Diagnosing this disease is still almost exclusively dependent on the clinical acumen of a patient's medical attendant. Until an objective method of identifying it clearly in the clinical setting is available, uncovering the aetiology is still unlikely. Until then, clear guidelines on the future incidence and prevalence of polymyalgia rheumatica and the public health problems of the disease and its management, especially in relation to the use of long term corticosteroids, will be difficult to provide.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Arterite de Células Gigantes/epidemiologia , Glucocorticoides/uso terapêutico , Polimialgia Reumática/epidemiologia , Diagnóstico Diferencial , Eletromiografia , Arterite de Células Gigantes/diagnóstico , Arterite de Células Gigantes/tratamento farmacológico , História do Século XX , História do Século XXI , Humanos , Polimialgia Reumática/diagnóstico , Polimialgia Reumática/tratamento farmacológico , Prognóstico , Escócia/epidemiologia
14.
Scott Med J ; 59(4): 220-8, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25201885

RESUMO

OBJECTIVES: On the 125th anniversary of the first recognised publication on polymyalgia rheumatica, a review of the literature was undertaken to assess what progress has been made from the point of view of the clinical care of affected patients. METHODS: The authors searched Medline and PubMed using the search terms 'polymyalgia rheumatica', 'giant cell arteritis' and 'temporal arteritis'. As much as possible, efforts were made to focus on studies where polymyalgia rheumatica and giant cell arteritis were treated as separate entities. The selection of articles was influenced by the authors' bias that polymyalgia rheumatica is a separate clinical condition from giant cell arteritis and that, as yet, the diagnosis is a clinical one. Apart from the elevation of circulating acute phase proteins, which has been recognised as a feature of polymyalgia rheumatica for over 60 years, the diagnosis receives no significant help from the laboratory or from diagnostic imaging. RESULTS: This review has shown that, following the recognition of polymyalgia as a distinct clinical problem of the elderly, the results of a considerable amount of research efforts including those using the advances in clinical imaging technology over the past 60 years, have done little to change the ability of clinicians to define the disease more accurately. Since the introduction of corticosteroids in the 1950s, there has been also very little change in the clinical management of the condition. CONCLUSIONS: Polymyalgia rheumatica remains a clinical enigma, and its relationship to giant cell arteritis is no clearer now than it has been for the past 125 years. Diagnosing this disease is still almost exclusively dependent on the clinical acumen of a patient's medical attendant. Until an objective method of identifying it clearly in the clinical setting is available, uncovering the aetiology is still unlikely, and until then, preventing the pain and stiffness of the disease while avoiding the problems of prolonged exoposure to corticosteroids is likely to remain elusive or serendipitous.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Arterite de Células Gigantes/diagnóstico , Glucocorticoides/uso terapêutico , Polimialgia Reumática/diagnóstico , Diagnóstico Diferencial , Eletromiografia , Arterite de Células Gigantes/tratamento farmacológico , Humanos , Polimialgia Reumática/tratamento farmacológico , Tomografia por Emissão de Pósitrons , Prognóstico , Escócia/epidemiologia
15.
Rev. colomb. reumatol ; 18(4): 260-270, oct.-dic. 2011. graf, tab
Artigo em Espanhol | LILACS | ID: lil-636871

RESUMO

Introducción: la polimialgia reumática (PMR) es una enfermedad inflamatoria que afecta a mayores de 50 años, caracterizada por dolor y rigidez en región cervical, cinturas escapular y pélvica y por una rápida respuesta a los glucocorticoides. Hasta donde sabemos, no hay estudios clínicos sobre PMR en nuestra población. Algunas enfermedades reumatológicas de comienzo tardío como artritis reumatoide (AR), lupus eritematoso sistémico (LES), espondiloartropatías y arteritis de células gigantes (ACG) pueden manifestarse con hallazgos de PMR. Igualmente, neoplasias hematológicas y algunos tumores sólidos pueden presentarse con un síndrome polimiálgico. Objetivo: analizar las características clínicas, de laboratorio y terapéuticas de pacientes de Medellín con PMR entre 1998 y 2011. Métodos: estudio descriptivo transversal. Se revisaron historias clínicas de pacientes con PMR y al menos 1 visita de seguimiento. Se analizaron variables sociales, demográficas, clínicas, de laboratorio y terapéuticas. Resultados: se evaluaron sesenta y nueve pacientes (79,7% mujeres), 68 (98,6%) de los cuales tuvieron dolor y/o rigidez en cintura escapular y 62 (89,8%) en cintura pélvica. La velocidad de sedimentación globular (VSG) fue igual o mayor a 40 mm/h en 43 (62,3%) pacientes y la proteína C reactiva (PCR) igual o mayor a 0,8 mg/dl en 56 (81,2%). El 76.9% de los pacientes recibieron prednisolona en dosis = 15 mg/día; 95,7% respondieron en los 3 primeros meses de tratamiento, 94,2% presentaron remisión (84,6% en los 6 primeros meses) y 39,1% tuvieron recaída (77,8% en el primer año de seguimiento). Los pacientes con VSG elevada tuvieron menor respuesta en el primer mes. Durante el seguimiento, 5 pacientes desarrollaron artritis reumatoide y 2 ACG. Conclusiones: los hallazgos encontrados aportan mayor información sobre las características de los pacientes con PMR en nuestra población y confirman la rápida respuesta al tratamiento con dosis bajas a moderadas de esteroides y menor respuesta inicial en pacientes con VSG elevada. Su diseño y tamaño de muestra son insuficientes para definir asociaciones estadísticamente significativas.


Background: Polymyalgia rheumatic is a syndrome that affects people over 50 years, characterized by pain and stiffness of shoulder and pelvic girdle. Its behavior in our population is unknown. It may be a manifestation of rheumatoid arthritis, systemic lupus erythematous, and neoplasm or could be associated with giant cells arteritis and it is a common indication for steroid usage. Objective: To analyze clinical, laboratory and treatment features of patients with PMR in Medellín between 1998-2011. Methodology: Descriptive cross-sectional study. We reviewed medical records of patients with PMR with at least 1 follow-up visit. We analyzed social, demographic, clinical, laboratory and therapeutic variables. Results: The records of 68 patients were assessed, 79.7% women. Pain and stiffness in shoulder and pelvic girdle were major symptoms. 62.3% had erythrocyte sedimentation rate equal to or greater than 40 mm/h and 81.2% had C reactive protein equal to or greater than 0.8 mg/dl. 76.9% received doses of prednisolone of 15 mg/day or below. 95.7% responded within the first 3 months of treatment, 94.2% showed remission (84.6% within the first 6 months), 39.1% relapsed (most within the first year of monitoring). Those with elevated ESR had a lower response in the first month. Five patients developed rheumatoid arthritis and two patients giant cells arteritis. Conclusions: These findings add more information about the clinical characteristics of patients with PMR. They allow suggesting early responses to treatment with low to moderate doses of steroids and a lower initial response in patients with elevated ESR. Design and sample size are insufficient to identify statistically significant associations.


Assuntos
Humanos , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Polimialgia Reumática , Dor , Neurite do Plexo Braquial , Neoplasias Hematológicas , Glucocorticoides
16.
Med. UIS ; 24(2): 167-172, mayo.-ago. 2011. tab
Artigo em Espanhol | LILACS | ID: lil-668956

RESUMO

Objetivo: determinar el papel de la biopsia de arteria temporal en el diagnóstico de arteritis temporal así como evaluar la efectividad de los criterios del ACR en el diagnóstico de esta entidad. Materiales y métodos: se realizó un estudio retrospectivo observacional descriptivo. Se revisaron informes de 40 biopsias de arteria temporal recibidas en el servicio de patología del Hospital Privado de Córdoba, Argentina entre 2000 y 2008. El total de biopsias se correlacionó con los hallazgos clínicos y de laboratorio. Resultados: 43% de las biopsias resultaron positivas para arteritis de células gigantes, mientras que 57% restante no cumplió los criterios histológicos. Al aplicar los criterios del Colegio Americano de Reumatología, 65% de los pacientes cumplió los criterios necesarios. De estos 26 individuos, 61% presentó biopsias positivas. De los pacientes que no reunían los criterios americanos, solo uno presentó positividad en la biopsia. Al tomar dichos criterios como parámetro de diagnóstico de la enfermedad y compararlos con la biopsia, cuentan con una sensibilidad de 94% y una especificidad de 56%, un valor predictivo positivo de 61% y un valor predictivo negativo de 93%. Los principales predictores de positividad en la biopsia fueron la claudicación mandibular (OR:6,76), las alteraciones visuales (OR:1,98) y las anomalías en el examen físico de las arterias temporales (OR:2,77). Discusión: el diagnóstico de arteritis de células gigantes surge a partir de la sospecha clínica y no siempre es confirmado por la histopatología. Es importante llegar al mismo debido al riesgo, sobretodo visual, que reviste no iniciar tratamiento con esteroides lo antes posible...


Objectives: to determine the role of temporal artery biopsies in the diagnosis of temporal arteritis and to assess the efficacy of ACR criteria in the recognition of this disease. Material and methods: a retrospective, descriptive, observational study was performed. A total of 40 reports of temporal artery biopsies were reviewed at the Pathology service of our institution between 2000 and 2008. These results were correlated with clinical and laboratory findings. Results: 43% of biopsies were positive for giant cell arteritis, while 57% did not meet histological criteria for giant cell arteritis. By applying the diagnostic criteria of the American College of Rheumatology, 65% of patients met the criteria for giant cell arteritis. Of these 26 individuals, 61% had positive biopsies, while the rest had negative results. From the patients who did not meet American criteria, only one had a positive biopsy. If we take the parameters of the American College of Rheumatology criteria for diagnosing the disease and compared them with the biopsy, we see that they have a sensitivity of 94% and a specificity of 56%; a positive predictive value of 61% and a negative predictive value of 93%. The main predictors of positive biopsy were jaw claudication (OR:6.76), visual disorders (OR:1.98) and abnormalities on physical examination of temporal arteries (OR:2.77). Discusion: giant cell arteritisdiagnosis mainly arises from the clinical suspicion and is not always confirmed by histopathology. It is important to reach its diagnosis because of the risk, primarily visual, that lies in not starting the steroid treatment as early as possible...


Assuntos
Biópsia , Arterite de Células Gigantes , Polimialgia Reumática
17.
Rev. argent. dermatol ; Rev. argent. dermatol;90(1): 86-90, ene.-mar. 2009. ilus
Artigo em Espanhol | LILACS | ID: lil-634381

RESUMO

Se comunica un caso de granuloma actínico en una paciente de sexo femenino, caucásica, la cual presentaba concomitantemente arteritis de la temporal y polimialgia reumática. Actualmente se considera que debido a la fisiopatogenia de las tres entidades mencionadas, podría tratarse la primera, de un marcador de las dos restantes.


We present a female, white, with an actinic granuloma, concomitantly with temporal arteritis and polymyalgia rheumatica. Today it is considered that, due to the phisiopathogenia of the three entities mentioned before, the first one could be used as a reference for the other two.

18.
Rev. colomb. reumatol ; 14(1): 66-84, ene. 2007. ilus
Artigo em Espanhol | LILACS | ID: lil-636752

RESUMO

Actualmente Colombia vive un cambio en la pirámide poblacional debido al incremento proporcional en sus ancianos, lo cual trae consigo mayor prevalencia de patologías que son importantes en la tercera edad. El envejecimiento conlleva a cambios fisiológicos normales en todos los sistemas, los cuales deben ser comprendidos para el adecuado análisis de la condición de salud de los ancianos. De la misma manera la presentación clínica y de laboratorio varía en el viejo y sumado a esto se presenta mayor comorbilidad y polifarmacia. Por tanto es importante conocer estas variantes en la atención del paciente mayor de 65 años. Las enfermedades reumatológicas no están exentas de lo anterior. La forma de presentación y el curso natural de enfermedades como osteoartritis, enfermedades por depósito de cristales, artritis reumatoide y lupus eritematoso sistémico pueden ser diferentes en los ancianos; además hay enfermedades características de esta edad, como es el caso de la polimialgia reumática, la arteritis de células gigantes y la mayor frecuencia del compromiso articular por cáncer. Se discutirán las manifestaciones clínicas y de laboratorio de estas enfermedades, enfocándose en el adecuado diagnóstico diferencial del compromiso articular en el anciano.


Currently Colombia lives a change in the populational pyramid due to the proportional increment in its elderly people, what lead to a greater prevalence of pathologies that are important in the third age. The aging involve normal physiologic changes in all the systems, which should be understood for the appropriate analysis of the condition of the elderly's health. In the same way the clinical and laboratory presentation varies in the elderly and there is also greater comorbilities and polifarmacy. Therefore it is important to know these variants in the attention of patients older than 65 years. Rheumatologic diseases are not exempt of the above mentioned. The form of presentation and the natural course of diseases like osteoarthritis, crystal-induced arthritis, rheumatoid arthritis and systemic lupus erythematosus can be different in the elderly; there are also characteristic diseases of this age, like polymialgia rheumatica, giant cell arteritis and a greater frequency of articular involvement by cancer. The clinical manifestations and laboratory findings of these diseases will be discussed, focusing in the appropriate differential diagnosis of the articular involvement in the elderly.


Assuntos
Humanos , Idoso , Artrite , Idoso , Colômbia , Sinais e Sintomas , Diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA